<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03456934</url>
  </required_header>
  <id_info>
    <org_study_id>15.09.INF</org_study_id>
    <nct_id>NCT03456934</nct_id>
  </id_info>
  <brief_title>Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease</brief_title>
  <acronym>BabyGrowth</acronym>
  <official_title>Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease: A Multi-centred, Randomised, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to investigate if consumption of lower protein formula
      can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age.
      Secondary objectives include investigation into whether infant nutrition and growth have an
      impact on later risk of obesity and cardiovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity and its cardiovascular consequences are the most important causes of morbidity and
      mortality worldwide. Breastfed infants have been shown to have less cardiovascular risk
      factors in adulthood, which can be partially explained by their slower growth compared to
      formula fed infants. The primary objective of this study is to investigate if consumption of
      lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and
      12 months of age. Secondary objectives include investigation into whether infant nutrition
      and growth have an impact on later risk of obesity and atherosclerotic cardiovascular disease
      (CVD), the critical windows for these programming effects, and the mechanisms of action.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 7, 2017</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized, double-blind with nonrandomized breast-fed reference group</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infant weight gain</measure>
    <time_frame>Between ages 14 weeks (+/- 1 week) and 12 months (+/- 2 weeks)</time_frame>
    <description>Rate of weight gain (g/d)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body mass index (BMI)-for-age Z-score</measure>
    <time_frame>Age 2 years (+/- 1 month)</time_frame>
    <description>Based on World Health Organization (WHO) growth standards</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height-for-age Z-score</measure>
    <time_frame>Age 2 years (+/- 1 month)</time_frame>
    <description>Based on WHO growth standards</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adiposity</measure>
    <time_frame>Age 2 years (+/- 1 month)</time_frame>
    <description>Sum of 4 skinfolds (triceps, biceps, sub-scapular, supra-iliac)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass</measure>
    <time_frame>Age 2 years (+/- 1 month)</time_frame>
    <description>Deuterium dilution (assessed in subset)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Infant weight gain</measure>
    <time_frame>Between 6 and 12 months</time_frame>
    <description>Rate of weight gain (g/d)</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>Ages 4, 5, 6, 12 and 24 months</time_frame>
    <description>Body weight (kg)</description>
  </other_outcome>
  <other_outcome>
    <measure>Length or height</measure>
    <time_frame>Ages 4, 5, 6, 12 and 24 months</time_frame>
    <description>Length or height (cm)</description>
  </other_outcome>
  <other_outcome>
    <measure>Head circumference</measure>
    <time_frame>Ages 4, 5, 6, 12 and 24 months</time_frame>
    <description>Head circumference (cm)</description>
  </other_outcome>
  <other_outcome>
    <measure>Body mass index</measure>
    <time_frame>Ages 6, 12 and 24 months</time_frame>
    <description>Weight and length or height will be combined to report BMI in kg/m^2</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight-for-age Z-score</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, 12 and 24 months</time_frame>
    <description>Based on WHO growth standards</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight-for-length Z-score</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, 12 and 24 months</time_frame>
    <description>Based on WHO growth standards</description>
  </other_outcome>
  <other_outcome>
    <measure>Height-for-age Z-score</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, and 12 months</time_frame>
    <description>Based on WHO growth standards</description>
  </other_outcome>
  <other_outcome>
    <measure>BMI-for-age Z-score</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, and 12 months</time_frame>
    <description>Based on WHO growth standards</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, 9, 12 and 24 months</time_frame>
    <description>Safety</description>
  </other_outcome>
  <other_outcome>
    <measure>Feeding intake</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, and 12 months</time_frame>
    <description>Infant feeding questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Feeding tolerance</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, and 12 months</time_frame>
    <description>GI symptom and stool pattern questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolic markers of cardiovascular health</measure>
    <time_frame>Ages 6 and 12 months</time_frame>
    <description>Blood sample (in a subset)</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood pressure</measure>
    <time_frame>At age 12 and 24 months</time_frame>
    <description>Systolic and diastolic blood pressure (in a subset)</description>
  </other_outcome>
  <other_outcome>
    <measure>Appetite and feeding / eating behavior</measure>
    <time_frame>Ages 14 weeks and 4, 5, 6, and 24 months</time_frame>
    <description>Baby and Children's Eating Behavior Questionnaire</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Infant Formula</condition>
  <condition>Growth</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Modified infant formula given from 3 to 12 months of age, as per standard requirement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard infant formula given from 3 to 12 months of age, as per standard requirement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast-fed Reference Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non-randomized infants who are predominantly breast-fed at time of enrollment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modified infant formula</intervention_name>
    <description>Test formula with lower protein content than standard formula</description>
    <arm_group_label>Experimental Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard infant formula</intervention_name>
    <description>Standard infant formula</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy term infant

          -  Infant is aged 14 weeks (+/- 1 week)

          -  Infant is exclusively formula feeding or predominantly breast-feeding at age 14 weeks

        Exclusion Criteria:

          -  Any adverse maternal, fetal or infant medical history that may have effects on growth
             and/or development

          -  Infant born with congenital disease or malformation affecting growth and/or
             development

          -  Food allergy to any trial products (e.g. milk, soy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Weeks</minimum_age>
    <maximum_age>15 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Atul Singhal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Childhood Nutrition Research Centre, University College London, Institute of Child Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie Lanigan, RD, PhD</last_name>
    <phone>+44 0207 905 2770</phone>
    <phone_ext>42770</phone_ext>
    <email>j.lanigan@ucl.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCL Institute of Child Health</name>
      <address>
        <city>London</city>
        <zip>WC1N 1EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Lanigan, RD, PhD</last_name>
      <phone>+44 0207 905 2770</phone>
      <phone_ext>42770</phone_ext>
      <email>j.lanigan@ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Atul Singhal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Protein requirements</keyword>
  <keyword>Adiposity</keyword>
  <keyword>Body composition</keyword>
  <keyword>Cardiovascular health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

